Molecular evolution of the HIV-1 thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial

Journal of Virology

Volumn 87, Issue 13, 2013, Pages 7265-7281

  Kijak, Gustavo H ^a,b   Tovanabutra, Sodsai ^a,b   Rerks Ngarm, Supachai ^c   Nitayaphan, Sorachai ^d   Eamsila, Chirapa ^d   Kunasol, Prayura ^c   Khamboonruang, Chirasak ^c   Thongcharoen, Prasert ^c   Namwat, Chawetsan ^c   Premsri, Nakorn ^c   Benenson, Michael ^d   Morgan, Patricia ^d   Bose, Meera ^a,b   Sanders Buell, Eric ^a,b   Paris, Robert ^d   Robb, Merlin L ^a,b   Birx, Deborah L ^b,e   De Souza, Mark S ^a,d   McCutchan, Francine E ^a,b,f   Michael, Nelson L ^b   Kim, Jerome H ^b   more..

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; GENE SEQUENCE; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; THAILAND; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN;

BASE SEQUENCE; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; FLOW CYTOMETRY; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; THAILAND; VIRAL VACCINES;

EID: 84880357204     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03070-12     Document Type: Article

References (85)

1. Kijak GH, McCutchan FE. 2005. HIV diversity, molecular epidemiology, and the role of recombination. Curr. Infect. Dis. Rep. 7:480-488.
2. Tebit DM, Arts EJ. 2011. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 11:45-56.
3. Kuiken C, Leithner T, Hahn B, Mullins J, Wolinsky S, Foley B, Apetrei C, Mizrahi I, Rambaut A, Korber B. 2012. HIV sequence compendium 2012. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.
4. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. 2008. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358:1590-1602.
5. Tovanabutra S, Birx D, McCutchan F. 2004. Molecular epidemiology of HIV in Asia and the Pacific. In Lu Y, Essex M (ed), AIDS in Asia. Kluwer Academic, New York, NY.
6. Nelson KE, Celentano DD, Suprasert S, Wright N, Eiumtrakul S, Tulvatana S, Matanasarawoot A, Akarasewi P, Kuntolbutra S, Romyen S, Sirisopana N, Theetranont C. 1993. Risk factors for HIV infection among young adult men in northern Thailand. JAMA 270:955-960.
7. Sirisopana N, Torugsa K, Mason CJ, Markowitz LE, Jugsudee A, Supapongse T, Chuenchitra C, Michael RA, Burke DS, Singharaj P, Johnson AE, McNeil JG, McCutchan FE, Carr JK. 1996. Correlates of HIV-1 seropositivity among young men in Thailand. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11:492-498.
8. Weniger BG, Limpakarnjanarat K, Ungchusak K, Thanprasertsuk S, Choopanya K, Vanichseni S, Uneklabh T, Thongcharoen P, Wasi C. 1991. The epidemiology of HIV infection and AIDS in Thailand. AIDS 5(Suppl 2):S71-S85.
9. Ou CY, Takebe Y, Luo CC, Kalish M, Auwanit W, Bandea C, de la Torre N, Moore JL, Schochetman G, Yamazaki S, Gayle HD, Young NL, Weniger BG. 1992. Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1471-1472.
10. McCutchan FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, Berman PW, Gray AM, Fowler AK, Burke DS. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1887-1895.
11. Ou CY, Takebe Y, Weniger BG, Luo CC, Kalish ML, Auwanit W, Yamazaki S, Gayle HD, Young NL, Schochetman G. 1993. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341:1171-1174.
12. Weniger BG, Takebe Y, Ou CY, Yamazaki S. 1994. The molecular epidemiology of HIV in Asia. AIDS 8(Suppl 2):S13-S28.
13. Mason CJ, Kitsiripornchai S, Markowitz LE, Chanbancherd P, Supapongse T, Jugsudee A, Sirisopana N, Chuenchitra C, Torugsa K, Van-Cott TC, Michael RA, Nitayaphan S. 1998. Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:165-173.
14. Entz AT, Ruffolo VP, Chinveschakitvanich V, Soskolne V, van Griensven GJ. 2000. HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea. AIDS 14:1027-1034.
15. Limpakarnjanarat K, Mastro TD, Saisorn S, Uthaivoravit W, Kaewkungwal J, Korattana S, Young NL, Morse SA, Schmid DS, Weniger BG, Nieburg P. 1999. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex. Transm. Infect. 75:30-35.
16. Beyrer C, Artenstein A, Kunawararak P, VanCott T, Mason C, Rungreungthanakit K, Hegerich P, Nelson KE, Khamboonruang C, Natpratan C. 1997. The molecular epidemiology of HIV-1 among male sex workers in northern Thailand. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:304-307.
17. Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, Young NL, Luo CC, Shaffer N, Kalish ML, Schochetman G. 1998. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res. Hum. Retroviruses 14:319-327.
18. Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, Kawichai S, Tanan P, Duerr A, Nelson KE. 2002. Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J. Acquir. Immune Defic. Syndr. 29:275-283.
19. Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S, Pau CP, Young NL. 1995. HIV-1 subtypes and male-tofemale transmission in Thailand. Lancet 345:1078-1083.
20. Kitayaporn D, Vanichseni S, Mastro TD, Raktham S, Vaniyapongs T, Des Jarlais DC, Wasi C, Young NL, Sujarita S, Heyward WL, Esparza J. 1998. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:289-295.
21. Vongsheree S, Phutiprawan T, Sri-ngam P, Thaisri H, Puangtabtim W, Sawanpanyalert P. 2002. Co-existence of HIV-1 subtypes B' and E infections among Thai injecting drug users. Asian Pac. J. Allergy Immunol. 20:29-35.
22. Ichimura H, Kliks SC, Visrutaratna S, Ou CY, Kalish ML, Levy JA. 1994. Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res. Hum. Retroviruses 10:263-269.
23. Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. 1998. Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. J. Infect. Dis. 178:1507-1511.
24. Auwanit W, Ayuthaya PI, Duangchanda S, Mukai T, Kurata T, Ikuta K. 2000. Highly variable sequences in the env V3 region of HIV type 1 distributing among Thai carriers from 1995 to 1997. AIDS Res. Hum. Retroviruses 16:283-289.
25. Utachee P, Jinnopat P, Isarangkura-Na-Ayuthaya P, de Silva UC, Nakamura S, Siripanyaphinyo U, Wichukchinda N, Tokunaga K, Yasunaga T, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M. 2009. Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand. AIDS Res. Hum. Retroviruses 25:229-236.
26. Wasi C, Herring B, Raktham S, Vanichseni S, Mastro TD, Young NL, Rubsamen-Waigmann H, von Briesen H, Kalish ML, Luo CC, Pau C-P, Baldwin A, Mullins JI, Delwart EL, Esparza J, Heyward WL, Osmanov S. 1995. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 9:843-849.
27. Kalish ML, Baldwin A, Raktham S, Wasi C, Luo CC, Schochetman G, Mastro TD, Young N, Vanichseni S, Rubsamen-Waigmann H, Vonbriesen H, Mullins JI, Delwart E, Herring B, Esparza J, Heyward WL, Osmanov S. 1995. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS 9:851-857.
28. Tovanabutra S, Beyrer C, Sakkhachornphop S, Razak MH, Ramos GL, Vongchak T, Rungruengthanakit K, Saokhieo P, Tejafong K, Kim B, De Souza M, Robb ML, Birx DL, Jittiwutikarn J, Suriyanon V, Celentano DD, McCutchan F.E. 2004. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res. Hum. Retroviruses 20:465-475.
29. Artenstein AW, VanCott TC, Mascola JR, Carr JK, Hegerich PA, Gaywee J, Sanders-Buell E, Robb ML, Dayhoff DE, Thitivichianlert S, Nitayaphan S, McNeil JG, Birx DL, Michael RA, Burke DS, McCutchan F.E. 1995. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J. Infect. Dis. 171:805-810.
30. Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, Mastro TD, Folks TM, Subbarao S. 2002. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 76:7444-7452.
31. Tovanabutra S, Polonis V, De Souza M, Trichavaroj R, Chanbancherd P, Kim B, Sanders-Buell E, Nitayaphan S, Brown A, Robb MR, Birx DL, McCutchan FE, Carr J.K. 2001. First CRF01_AE/B recombinant of HIV-1 is found in Thailand. AIDS 15:1063-1065.
32. Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S, Khamboonrueng C, Birx DL, Robb ML, McCutchan F.E. 2007. Distinguishing molecular forms of HIV-1 in Asia with a highthroughput, highthroughput, fluorescent genotyping assay, MHAbce v. 2. Virology 358:178-191.
33. Viputtijul K, de Souza M, Trichavaroj R, Carr JK, Tovanabutra S, McCutchan FE, Sriplienchan S, Buapunth P, Chuenchitra C, McNeil JG, Birx DL, Brown AE, Nitayaphan S. 2002. Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. AIDS Res. Hum. Retroviruses 18:1235-1237.
34. Takebe Y, Motomura K, Tatsumi M, Lwin HH, Zaw M, Kusagawa S. 2003. High prevalence of diverse forms of HIV-1 intersubtype recombinants in central Myanmar: geographical hot spot of extensive recombination. AIDS 17:2077-2087.
35. Liao H, Tee KK, Hase S, Uenishi R, Li XJ, Kusagawa S, Thang PH, Hien NT, Pybus OG, Takebe Y. 2009. Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. Virology 391:51-56.
36. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J, Wagner R, Wolf H, Shao Y, Lai S, Beyrer C, Yu X.F. 2000. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J. Virol. 74:11286-11295.
37. Sukasem C, Churdboonchart V, Chasombat S, Kohreanudom S, Watitpun C, Pasomsub E, Piroj W, Tiensuwan M, Chantratita W. 2007. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand. Infection 35:81-88.
38. Praparattanapan J, Tragoolpua Y, Pathom-aree W, Kotarathitithum W, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K. 2011. Current molecular epidemiology and recombination of HIV type 1 subtypes in northern Thailand. AIDS Res. Hum. Retroviruses 27:1201-1206.
39. Sirivichayakul S, Phanuphak P, Pankam T, O-Charoen R, Sutherland D, Ruxrungtham K. 2008. HIV drug resistance transmission threshold survey in Bangkok, Thailand. Antivir. Ther. 13(Suppl 2):109-113.
40. Watanaveeradej V, Benenson MW, Souza MD, Sirisopana N, Nitayaphan S, Tontichaivanich C, Amphaipit R, Renzullo PO, Brown AE, McNeil JG, Robb ML, Birx DL, Tovanabutra S, Carr JK, McCutchan F.E. 2006. Molecular epidemiology of HIV type 1 in preparation for a phase III prime-boost vaccine trial in Thailand and a new approach to HIV type 1 genotyping. AIDS Res. Hum. Retroviruses 22:801-807.
41. Ministry of Public Health-Thai AIDS Vaccine Evaluation Group. 2011. Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148). Vaccine 29: 4285-4292.
42. Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, Decamp AC, Carrico C, Menis S, Magaret CA, Ahmed H, Juraska M, Chen L, Konopa P, Nariya S, Stoddard JN, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Bates A, Lazzaro M, O'Sullivan A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connell RJ, Desouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McLellan JS, Georgiev I, Kwong PD, Carlson JM, Michael NL, Schief WR, Gilbert PB, Mullins JI, Kim J.H. 2012. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 490:417-420.
43. Ministry of Public Health of Thailand. 2000. National guidelines for clinical management of HIV/AIDS in adults and children. Ministry of Public Health, Bangkok, Thailand.
44. Tovanabutra S, Sanders EJ, Graham SM, Mwangome M, Peshu N, McClelland RS, Muhaari A, Crossler J, Price MA, Gilmour J, Michael NL, McCutchan F.M. 2010. Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya. AIDS Res. Hum. Retroviruses 26:123-131.
45. Hall T. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
46. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
47. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
48. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
49. Schultz AK, Zhang M, Bulla I, Leitner T, Korber B, Morgenstern B, Stanke M. 2009. jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res. 37:W647-W651. doi:10.1093/nar/gkp371.
50. Pond SL, Frost SD, Muse S.V. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676-679.
51. Zuckerkandl E, Pauling L. 1965. Evolutionary divergence and convergence in proteins, p 97-166. In Bryson V, VogelH(ed), Evolving genes and proteins. Academic Press, New York, N.Y.
52. Jones DT, Taylor WR, Thornton J.M. 1992. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 8:275-282.
53. Schwartz RM, Dayhoff M.O. 1979. Protein and nucleic acid sequence data and phylogeny. Science 205:1038-1039.
54. Nickle DC, Heath L, Jensen MA, Gilbert PB, Mullins JI, Kosakovsky Pond S.L. 2007. HIV-specific probabilistic models of protein evolution. PLoS One 2:e503. doi:10.1371/journal.pone.0000503.
55. Kijak GH, Tovanabutra S, Beyrer C, Sanders-Buell EE, Arroyo MA, Robb ML, Michael NL, McCutchan FE, Kim J.H. 2010. RecDraw: a software package for the representation of HIV-1 recombinant structures. AIDS Res. Hum. Retroviruses 26:1317-1321.
56. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim J.H. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361: 2209-2220.
57. Kalish ML, Luo CC, Weniger BG, Limpakarnjanarat K, Young N, Ou CY, Schochetman G. 1994. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res. Hum. Retroviruses 10: 1573-1575.
58. Graf M, Shao Y, Zhao Q, Seidl T, Kostler J, Wolf H, Wagner R. 1998. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res. Hum. Retroviruses 14:285-288.
59. Tovanabutra S, Watanaveeradej V, Viputtikul K, De Souza M, Razak MH, Suriyanon V, Jittiwutikarn J, Sriplienchan S, Nitayaphan S, Benenson MW, Sirisopana N, Renzullo PO, Brown AE, Robb ML, Beyrer C, Celentano DD, McNeil JG, Birx DL, Carr JK, McCutchan F.E. 2003. A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res. Hum. Retroviruses 19:561-567.
60. Herbinger KH, Gerhardt M, Piyasirisilp S, Mloka D, Arroyo MA, Hoffmann O, Maboko L, Birx DL, Mmbando D, McCutchan FE, Hoelscher M. 2006. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low-and high-risk populations in Mbeya Region, Tanzania. AIDS Res. Hum. Retroviruses 22:599-606.
61. Kijak GH, Beyrer C, Tovanabutra S, Sripaipan T, Suriyanon V, Moqueet N, Sanders-Buell E, Saokhieo P, Timpan U, Jittiwutikarn J, Robb ML, Birx DL, Celentano DD, McCutchan F.E. 2011. Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in northern Thai drug users: associations of risk with genetic complexity. Drug Alcohol Depend. 116:24-30.
62. Arroyo MA, Hoelscher M, Sateren W, Samky E, Maboko L, Hoffmann O, Kijak G, Robb M, Birx DL, McCutchan F.E. 2005. HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 19:1517-1524.
63. Arroyo MA, Sateren WB, Foglia G, Kibaya R, Langat L, Wasunna M, Bautista CT, Scott PT, Shaffer DN, Robb ML, Michael NL, Birx DL, McCutchan F.E. 2009. Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya. AIDS Res. Hum. Retroviruses 25:1061-1064.
64. Arroyo MA, Sateren WB, Serwadda D, Gray RH, Wawer MJ, Sewankambo NK, Kiwanuka N, Kigozi G, Wabwire-Mangen F, Eller M, Eller LA, Birx DL, Robb ML, McCutchan F.E. 2006. Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda. J. Acquir. Immune Defic. Syndr. 43:440-445.
65. Land AM, Luo M, Pilon R, Sandstrom P, Embree J, Wachihi C, Kimani J, Plummer FA, Ball T.B. 2008. High prevalence of genetically similar HIV-1 recombinants among infected sex workers in Nairobi, Kenya. AIDS Res. Hum. Retroviruses 24:1455-1460.
66. Khawcharoenporn T, Apisarnthanarak A, Gesprasert G, Jaiyen Y, Mundy LM, Thitithanyanont A. 2011. Predictors for recombinant HIV infection in a Thai cohort. Sex. Transm. Dis. 38:1046-1049.
67. Rerks-Ngarm S, Brown AE, Khamboonruang C, Thongcharoen P, Kunasol P. 2006. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand. AIDS 20:1471-1479.
68. Tomaras GD, Binley JM, Gray ES, Crooks ET, Osawa K, Moore PL, Tumba N, Tong T, Shen X, Yates NL, Decker J, Wibmer CK, Gao F, Alam SM, Easterbrook P, Abdool Karim S, Kamanga G, Crump JA, Cohen M, Shaw GM, Mascola JR, Haynes BF, Montefiori DC, Morris L. 2011. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J. Virol. 85:11502-11519.
69. Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, Lai Z, Honnen WJ, Nonyane M, Tumba N, Hermanus T, Sibeko S, Mlisana K, Abdool Karim SS, Williamson C, Pinter A, Morris L. 2011. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J. Virol. 85:3128-3141.
70. van Gils MJ, Bunnik EM, Boeser-Nunnink BD, Burger JA, Terlouw-Klein M, Verwer N, Schuitemaker H. 2011. Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J. Virol. 85:6986-6995.
71. Chaillon A, Braibant M, Moreau T, Thenin S, Moreau A, Autran B, Barin F. 2011. The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12. J. Virol. 85: 3642-3648.
72. Saunders CJ, McCaffrey RA, Zharkikh I, Kraft Z, Malenbaum SE, Burke B, Cheng-Mayer C, Stamatatos L. 2005. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 79:9069-9080.
73. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, Fong Y, Janes H, DeCamp A, Huang Y, Rao M, Billings E, Karasavvas N, Robb ML, Ngauy V, de Souza MS, Paris R, Ferrari G, Bailer RT, Soderberg KA, Andrews C, Berman PW, Frahm N, De Rosa SC, Alpert MD, Yates NL, Shen X, Koup RA, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Kim J.H. 2012. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366:1275-1286.
74. Ng OT, Eyzaguirre LM, Carr JK, Chew KK, Lin L, Chua A, Leo YS, Redd AD, Quinn TC, Laeyendecker O. 2012. Identification of new CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. AIDS Res. Hum. Retroviruses 28:527-530.
75. Swanson P, Devare SG, Hackett J, Jr. 2003. Full-length sequence analysis of HIV-1 isolate CM237: a CRF01_AE/B intersubtype recombinant from Thailand. AIDS Res. Hum. Retroviruses 19:707-712.
76. Tovanabutra S, Kijak GH, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, Vongchak T, Jittiwutikarn J, Razak MH, Sanders-Buell E, Robb ML, Suriyanon V, Birx DL, Michael NL, Celentano DD, Mc-Cutchan F.E. 2007. Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. AIDS Res. Hum. Retroviruses 23:829-833.
77. McCutchan FE, Hoelscher M, Tovanabutra S, Piyasirisilp S, Sanders-Buell E, Ramos G, Jagodzinski L, Polonis V, Maboko L, Mmbando D, Hoffmann O, Riedner G, von Sonnenburg F, Robb M, Birx D.L. 2005. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J. Virol.79:11693-11704.
78. Carr JK, Avila M, Gomez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V, Pando MA, Negrete M, Russell KL, Sanchez J, Birx DL, Andrade R, Vinoles J, McCutchan F.E. 2001. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 15:F41-F47.
79. McCutchan FE, Carr JK, Murphy D, Piyasirisilp S, Gao F, Hahn B, Yu XF, Beyrer C, Birx D.L. 2002. Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res. Hum. Retroviruses 18:1135-1140.
80. Fan J, Negroni M, Robertson D.L. 2007. The distribution of HIV-1 recombination breakpoints. Infect. Genet. Evol. 7:717-723.
81. Levy J.A. 2007. HIV and the pathogenesis of AIDS, 3rd ed. ASM Press, Washington, D.C.
82. Delgado E, Thomson MM, Villahermosa ML, Sierra M, Ocampo A, Miralles C, Rodriguez-Perez R, Diz-Aren J, Ojea-de Castro R, Losada E, Cuevas MT, Vazquez-de Parga E, Carmona R, Perez-Alvarez L, Medrano L, Cuevas L, Taboada JA, Najera R. 2002. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J. Acquir. Immune Defic. Syndr. 29:536-543.
83. Arroyo MA, Phanuphak N, Krasaesub S, Sirivichayakul S, Assawadarachai V, Poltavee K, Pankam T, Ananworanich J, Paris R, Tovanabutra S, Kijak GH, McCutchan FE, Phanuphak P, Kim JH, de Souza M. 2010.HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross anonymous clinic in Bangkok, Thailand. AIDS Res. Hum. Retroviruses 26:5-12.
84. Robb ML, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Kunasol P, Khamboonruang C, Thongcharoen P, Morgan P, Benenson M, Paris RM, Chiu J, Adams E, Francis D, Gurunathan S, Tartaglia J, Gilbert P, Stablein D, Michael NL, Kim J.H. 2012. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect. Dis. 12:531-537.
85. Tovanabutra S, Brodine SK, Mascola JR, Sankale JL, Sanders-Buell E, Kim B, Birx DL, McCutchan F.E. 2005. Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel. AIDS Res. Hum. Retroviruses 21:424-429.